Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support

Boston Children's Hospital logo

Boston Children's Hospital

Status

Enrolling

Conditions

Drug Effect

Treatments

Drug: Morphine
Drug: Dexmedetomidine
Drug: Fentanyl
Drug: Midazolam

Study type

Observational

Funder types

Other

Identifiers

NCT03593408
IRB-P00028380

Details and patient eligibility

About

This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.

Enrollment

20 estimated patients

Sex

All

Ages

Under 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • supported on ECMO
  • receiving one or a combination of the following drugs dexmedetomidine, fentanyl, midazolam or morphine as part of sedation management

Exclusion criteria

-none

Trial design

20 participants in 1 patient group

Pediatric Patients on ECMO Support
Treatment:
Drug: Midazolam
Drug: Fentanyl
Drug: Dexmedetomidine
Drug: Morphine

Trial contacts and locations

1

Loading...

Central trial contact

Viviane Nasr, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems